The study demonstrates that all three domains of β-synuclein contribute to inhibiting α-synuclein aggregation through 'transient, multi-pronged interactions,' but the specific molecular mechanisms remain unexplained. Understanding these mechanisms is critical for designing therapeutic mimetics of β-synuclein's protective effects. Gap type: unexplained_observation Source paper: Multi-Pronged Interactions Underlie Inhibition of α-Synuclein Aggregation by β-Synuclein. (2018, Journal of molecular biology, PMID:29782835)
Landscape Summary: What are the molecular mechanisms underlying β-synuclein's multi-pronged inhibitory interactions with α-synuclein? is a 0.8 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the molecular mechanisms underlying β-synuclein's multi-pronged inhibitory interactions with α-synuclein? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: